Impact Respiratory RNA Virus Diseases' and the rapidly evolving subject area, we are pleased to launch Volume II for this topic.The threat posed by avian influenza to humans today, the possibility of ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional CD8 + T cells in patients with pancreatic ductal adenocarcinoma (PDAC), ...

While the concept is well established and several RNAi drugs have reached the clinic, their effectiveness has often been limited by the challenge of delivering fragile RNA molecules intact to the ...

The rapid evolutionary dynamics of RNA viruses, driven by high mutation rates and the consequent formation of complex ...

UVA infectious disease expert Dr. William Petri explains how the virus spreads and why health officials are on high alert.

European regulators have started a review of Amgen’s drug Tavneos following “emerging information that raises questions ...

Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...

Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.

In a university news release, senior author Donald Milton, MD, DrPH, of UM, said, “Our results suggest that portable air ...

A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces ...

Yeast-based protein expression systems will likely play an important role in vaccine production during future pandemics.